211 related articles for article (PubMed ID: 35893811)
1. Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products.
Agonia AS; Palmeira-de-Oliveira A; Cardoso C; Augusto C; Pellevoisin C; Videau C; Dinis-Oliveira RJ; Palmeira-de-Oliveira R
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893811
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average Bioequivalence.
Shin SH; Rantou E; Raney SG; Ghosh P; Hassan H; Stinchcomb A
Pharm Res; 2020 Oct; 37(10):210. PubMed ID: 33001286
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies into establishing therapeutic bioequivalence of complex topical products: Weight of evidence.
Miranda M; Volmer Z; Cornick A; Goody A; Cardoso C; Pais AACC; Brown M; Vitorino C
Int J Pharm; 2024 May; 656():124012. PubMed ID: 38537923
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations.
Santos LL; Swofford NJ; Santiago BG
Curr Protoc Pharmacol; 2020 Dec; 91(1):e79. PubMed ID: 32991075
[TBL] [Abstract][Full Text] [Related]
5. Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams.
Mohammed YH; Namjoshi SN; Jung N; Windbergs M; Benson HAE; Grice JE; Raney SG; Roberts MS
Pharm Res; 2024 Jul; ():. PubMed ID: 38955999
[TBL] [Abstract][Full Text] [Related]
6. Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay.
Lehman PA; Franz TJ
Pharm Res; 2014 Dec; 31(12):3529-37. PubMed ID: 25005736
[TBL] [Abstract][Full Text] [Related]
7. Topical bioequivalence: Experimental and regulatory considerations following formulation complexity.
Miranda M; Veloso C; Brown M; C Pais AAC; Cardoso C; Vitorino C
Int J Pharm; 2022 May; 620():121705. PubMed ID: 35358644
[TBL] [Abstract][Full Text] [Related]
8. Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro.
Salminen AT; Davis KJ; Felton RP; Nischal N; VonTungeln LS; Beland FA; Derr K; Brown PC; Ferrer M; Katz LM; Kleinstreuer NC; Leshin J; Manga P; Sadrieh N; Xia M; Fitzpatrick SC; Camacho L
Toxicol In Vitro; 2023 Sep; 91():105630. PubMed ID: 37315744
[TBL] [Abstract][Full Text] [Related]
9. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study.
Schäfer-Korting M; Bock U; Diembeck W; Düsing HJ; Gamer A; Haltner-Ukomadu E; Hoffmann C; Kaca M; Kamp H; Kersen S; Kietzmann M; Korting HC; Krächter HU; Lehr CM; Liebsch M; Mehling A; Müller-Goymann C; Netzlaff F; Niedorf F; Rübbelke MK; Schäfer U; Schmidt E; Schreiber S; Spielmann H; Vuia A; Weimer M
Altern Lab Anim; 2008 May; 36(2):161-87. PubMed ID: 18522484
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model.
Arora S; Clarke J; Tsakalozou E; Ghosh P; Alam K; Grice JE; Roberts MS; Jamei M; Polak S
Mol Pharm; 2022 Sep; 19(9):3139-3152. PubMed ID: 35969125
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
[TBL] [Abstract][Full Text] [Related]
12. Effect of Controlled Heat Application on Topical Diclofenac Formulations Evaluated by In Vitro Permeation Tests (IVPT) Using Porcine and Human Skin.
Thomas S; Shin SH; Hammell DC; Hassan HE; Stinchcomb AL
Pharm Res; 2020 Feb; 37(3):49. PubMed ID: 32034502
[TBL] [Abstract][Full Text] [Related]
13. Relating transdermal delivery plasma pharmacokinetics with in vitro permeation test (IVPT) findings using diffusion and compartment-in-series models.
Liu X; Anissimov YG; Grice JE; Cheruvu HS; Ghosh P; Raney SG; Maibach HI; Roberts MS
J Control Release; 2021 Jun; 334():37-51. PubMed ID: 33857564
[TBL] [Abstract][Full Text] [Related]
14. Drilling down the bioequivalence assessment of topical antifungal products: Microstructure and release.
Miranda M; Cardoso C; Pais AACC; Brown M; Vitorino C
Eur J Pharm Biopharm; 2023 Apr; 185():94-106. PubMed ID: 36806630
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Evaluation of Desoximetasone Cream and Ointment Formulations Using Experiments and In Silico Modeling.
Matharoo NS; Garimella HT; German C; Przekwas AJ; Michniak-Kohn B
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894801
[TBL] [Abstract][Full Text] [Related]
16. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.
Liu X; Yousef S; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Grice JE; Roberts MS
Eur J Pharm Biopharm; 2020 Apr; 149():30-44. PubMed ID: 32018051
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence of topical clotrimazole formulations: an improved tape stripping method.
Parfitt NR; Skinner MF; Bon C; Kanfer I
J Pharm Pharm Sci; 2011; 14(3):347-57. PubMed ID: 21906479
[TBL] [Abstract][Full Text] [Related]
19. Confocal Raman spectroscopy coupled with in vitro permeation testing to study the effects of formalin fixation on the skin barrier function of reconstructed human epidermis.
Kichou H; Bonnier F; Caritá AC; Byrne HJ; Chourpa I; Munnier E
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 320():124617. PubMed ID: 38870697
[TBL] [Abstract][Full Text] [Related]
20. A comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams.
Wellington H; Rath S; Kanfer I
Eur J Pharm Sci; 2024 Jan; 192():106649. PubMed ID: 37992910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
